KWAR23 is an anti-human SIRPα антитело. KWAR23 binds human SIRPα with high affinity and disrupts its связывание to CD47. KWAR23 shows antitumor activity in combination with tumor-opsonizing antibodies and can be used in cancer immunotherapy research.
KWAR23 is an anti-human SIRPα antibody. KWAR23 binds human SIRPα with high affinity and disrupts its binding to CD47. KWAR23 shows antitumor activity in combination with tumor-opsonizing antibodies and can be used in cancer immunotherapy research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.